{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:32:39Z","timestamp":1787236359113,"version":"build-2736575974"},"reference-count":31,"publisher":"Japan Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1507\/endocrj.ej18-0396","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T17:33:14Z","timestamp":1551202394000},"page":"423-430","source":"Crossref","is-referenced-by-count":37,"title":["Upregulated tissue expression of T helper (Th) 17 pathogenic interleukin (IL)-23 and IL-1\u03b2 in Hashimoto\u2019s thyroiditis but not in Graves\u2019 disease"],"prefix":"10.1507","volume":"66","author":[{"given":"Tatjana","family":"Zake","sequence":"first","affiliation":[{"name":"Institute of Anatomy and Anthropology, Riga Stradins University, Riga, LV-1010, Latvia"},{"name":"Department of Internal Medicine, Riga Stradins University, Riga, LV-1007 Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Skuja","sequence":"additional","affiliation":[{"name":"Institute of Anatomy and Anthropology, Riga Stradins University, Riga, LV-1010, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ieva","family":"Kalere","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Riga Stradins University, Riga, LV-1007 Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilze","family":"Konrade","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Riga Stradins University, Riga, LV-1007 Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerija","family":"Groma","sequence":"additional","affiliation":[{"name":"Institute of Anatomy and Anthropology, Riga Stradins University, Riga, LV-1010, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, et al. (1995) The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 43: 55\u201368.","DOI":"10.1111\/j.1365-2265.1995.tb01894.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Fr\u00f6hlich E, Wahl R (2017) Thyroid autoimmunity: role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases. Front Immunol 8: 521.","DOI":"10.3389\/fimmu.2017.00521"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Kaczur V, Vereb G, Molnar I, Krajczar G, Kiss E, et al. (1997) Effect of anti-thyroid peroxidase (TPO) antibodies on TPO activity measured by chemiluminescence assay. Clin Chem 43: 1392\u20131396.","DOI":"10.1093\/clinchem\/43.8.1392"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Ruggeri RM, Vicchio TM, Cristani M, Certo R, Caccamo D, et al. (2016) Oxidative stress and advanced glycation end products in Hashimoto\u2019s thyroiditis. Thyroid 26: 504\u2013511.","DOI":"10.1089\/thy.2015.0592"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Salmaso C, Bagnasco M, Pesce G, Montagna P, Brizzolara R, et al. (2002) Regulation of apoptosis in endocrine autoimmunity: insights from Hashimoto\u2019s thyroiditis and Graves\u2019 disease. Ann N Y Acad Sci 966: 496\u2013501.","DOI":"10.1111\/j.1749-6632.2002.tb04253.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Adami S, Cavani A, Rossi F, Girolomoni G (2014) The role of interleukin-17A in psoriatic disease. BioDrugs 28: 487\u2013497.","DOI":"10.1007\/s40259-014-0098-x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Hot A, Miossec P (2011) Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes. Ann Rheum Dis 70: 727\u2013732.","DOI":"10.1136\/ard.2010.143768"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Piper C, Pesenacker AM, Bending D, Thirugnanabalan B, Varsani H, et al. (2014) T cell expression of granulocyte-macrophage colony-stimulating factor in juvenile arthritis is contingent upon Th17 plasticity. Arthritis Rheumatol 66: 1955\u20131960.","DOI":"10.1002\/art.38647"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Peck A, Mellins ED (2010) Plasticity of T-cell phenotype and function: the T helper type 17 example. Immunology 129: 147\u2013153.","DOI":"10.1111\/j.1365-2567.2009.03189.x"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10 Chung Y, Chang SH, Martinez GJ, Yang XO, Nurieva R, et al. (2009) Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30: 576\u2013587.","DOI":"10.1016\/j.immuni.2009.02.007"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Stadhouders R, Lubberts E, Hendriks RW (2018) A cellular and molecular view of T helper 17 cell plasticity in autoimmunity. J Autoimmun 87: 1\u201315.","DOI":"10.1016\/j.jaut.2017.12.007"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Croxford AL, Mair F, Becher B (2012) IL-23: one cytokine in control of autoimmunity. Eur J Immunol 42: 2263\u20132273.","DOI":"10.1002\/eji.201242598"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Ruggeri RM, Saitta S, Cristani M, Giovinazzo S, Tigano V, et al. (2014) Serum interleukin-23 (IL-23) is increased in Hashimoto\u2019s thyroiditis. Endocr J 61: 359\u2013363.","DOI":"10.1507\/endocrj.EJ13-0484"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Zheng T, Xu C, Mao C, Mou X, Wu F, et al. (2018) Increased interleukin-23 in Hashimoto\u2019s thyroiditis disease induces autophagy suppression and reactive oxygen species accumulation. Front Immunol 9: 96.","DOI":"10.3389\/fimmu.2018.00096"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Rebuffat SA, Kammoun-Krichen M, Charfeddine I, Ayadi H, Bougacha-Elleuch N, et al. (2013) IL-1beta and TSH disturb thyroid epithelium integrity in autoimmune thyroid diseases. Immunobiology 218: 285\u2013291.","DOI":"10.1016\/j.imbio.2012.05.016"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Lee Y, Kuchroo V (2015) Defining the functional states of Th17 cells. F1000Res 4: 132.","DOI":"10.12688\/f1000research.6116.1"},{"key":"17","unstructured":"17 Zake T, Skuja S, Kalere I, Konrade I, Groma V (2018) Heterogeneity of tissue IL-17 and tight junction proteins expression demonstrated in patients with autoimmune thyroid diseases. Medicine (Baltimore) 97: e11211."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Bedoya SK, Lam B, Lau K, Larkin J Jr (2013) Th17 cells in immunity and autoimmunity. Clin Dev Immunol 2013: 986789.","DOI":"10.1155\/2013\/986789"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Park H, Li Z, Yang XO, Chang SH, Nurieva R, et al. (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6: 1133\u20131141.","DOI":"10.1038\/ni1261"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Figueroa-Vega N, Alfonso-P\u00e9rez M, Benedicto I, S\u00e1nchez-Madrid F, Gonz\u00e1lez-Amaro R, et al. (2010) Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto\u2019s thyroiditis. J Clin Endocrinol Metab 95: 953\u2013962.","DOI":"10.1210\/jc.2009-1719"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21 Nanba T, Watanabe M, Inoue N, Iwatani Y (2009) Increases of the Th1\/Th2 cell ratio in severe Hashimoto\u2019s disease and in the proportion of Th17 cells in intractable Graves\u2019 disease. Thyroid 19: 495\u2013501.","DOI":"10.1089\/thy.2008.0423"},{"key":"22","doi-asserted-by":"crossref","unstructured":"23 Qin Q, Liu P, Liu L, Wang R, Yan N, et al. (2012) The increased but non-predominant expression of Th17- and Th1-specific cytokines in Hashimoto\u2019s thyroiditis but not in Graves\u2019 disease. Braz J Med Biol Res 45: 1202\u20131208.","DOI":"10.1590\/S0100-879X2012007500168"},{"key":"23","doi-asserted-by":"crossref","unstructured":"24 Codarri L, Gy\u00fclv\u00e9szii G, Tosevski V, Hesske L, Fontana A, et al. (2011) ROR\u03b33t drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat Immunol 12: 560\u2013567.","DOI":"10.1038\/ni.2027"},{"key":"24","doi-asserted-by":"crossref","unstructured":"25 Langowski JL, Zhang X, Wu L, Mattson JD, Chen T, et al. (2006) IL-23 promotes tumour incidence and growth. Nature 442: 461\u2013465.","DOI":"10.1038\/nature04808"},{"key":"25","doi-asserted-by":"publisher","unstructured":"26 Ghoreschi K, Laurence A, Yang XP, Tato CM, McGeachy MJ, et al. (2010) Generation of pathogenic Th17 cells in the absence of TGF-\u03b2 signaling. Nature 467: 967\u2013971.","DOI":"10.1038\/nature09447"},{"key":"26","unstructured":"27 Ruggeri RM, Cristani M, Vicchio TM, Alibrandi A, Giovinazzo S, et al. (2018) Increased serum interleukin-37 (IL-37) levels correlate with oxidative stress parameters in Hashimoto\u2019s thyroiditis. J Endocrinol Invest: 1\u20137."},{"key":"27","doi-asserted-by":"crossref","unstructured":"28 Jia H, Tao F, Liu C, Guo T, Zhu W, et al. (2015) Both interleukin-23A polymorphism and serum interlukin-23 expression are associated with Graves\u2019 disease risk. Cell Immunol 294: 39\u201343.","DOI":"10.1016\/j.cellimm.2015.01.015"},{"key":"28","doi-asserted-by":"crossref","unstructured":"29 Zheng L, Ye P, Liu C (2013) The role of the IL-23\/IL-17 axis in the pathogenesis of Graves\u2019 disease. Endocr J 60: 591\u2013597.","DOI":"10.1507\/endocrj.EJ12-0264"},{"key":"29","doi-asserted-by":"crossref","unstructured":"30 Huber AK, Jacobson EM, Jazdzewski K, Concepcion ES, Tomer Y (2008) Interleukin (IL)-23 receptor is a major susceptibility gene for Graves\u2019 ophthalmopathy: the IL-23\/T-helper 17 axis extends to thyroid autoimmunity. J Clin Endocrinol Metab 93: 1077\u20131081.","DOI":"10.1210\/jc.2007-2190"},{"key":"30","doi-asserted-by":"crossref","unstructured":"31 Paolieri F, Salmaso C, Battifora M, Montagna P, Pesce G, et al. (1999) Possible pathogenetic relevance of interleukin-1 beta in \u201cdestructive\u201d organ-specific autoimmune disease (Hashimoto\u2019s thyroiditis). Ann N Y Acad Sci 876: 221\u2013228.","DOI":"10.1111\/j.1749-6632.1999.tb07642.x"},{"key":"31","doi-asserted-by":"publisher","unstructured":"32 Vitales-Noyola M, Ramos-Levi AM, Martinez-Hernandez R, Serrano-Somavilla A, Sampedro-Nunez M, et al. (2017) Pathogenic Th17 and Th22 cells are increased in patients with autoimmune thyroid disorders. Endocrine 57: 409\u2013417.","DOI":"10.1007\/s12020-017-1361-y"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/66\/5\/66_EJ18-0396\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T12:25:44Z","timestamp":1606566344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/66\/5\/66_EJ18-0396\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej18-0396","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}